Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mannatech

This article was originally published in The Tan Sheet

Executive Summary

Restructuring shifts marketing directly under CEO Bob Henry, who also oversees international operations, while R&D is placed under President/COO Terry Persinger, Coppell, Tex.-based multi-level supplement marketer announces April 20. Marketing Senior VP Brad Wayment will report to Henry, while Senior VP/Chief Scientific Officer Bill McAnalley, PhD, will answer to Persinger. Also, Eileen Vennum named VP-glycoscience information and Stephen Boyd, MD, named medical director. Moves aimed at consolidating marketing and overseas business, company explains

Restructuring shifts marketing directly under CEO Bob Henry, who also oversees international operations, while R&D is placed under President/COO Terry Persinger, Coppell, Tex.-based multi-level supplement marketer announces April 20. Marketing Senior VP Brad Wayment will report to Henry, while Senior VP/Chief Scientific Officer Bill McAnalley, PhD, will answer to Persinger. Also, Eileen Vennum named VP-glycoscience information and Stephen Boyd, MD, named medical director. Moves aimed at consolidating marketing and overseas business, company explains.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel